Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
about
Cell membrane modulation as adjuvant in cancer therapyMetabolomic profiling of ascending thoracic aortic aneurysms and dissections - Implications for pathophysiology and biomarker discoveryEfficient replacement of plasma membrane outer leaflet phospholipids and sphingolipids in cells with exogenous lipidsSphingolipids in mitochondria.Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study.Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthases.Inhibitors of ceramide de novo biosynthesis rescue damages induced by cigarette smoke in airways epithelia.Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site-engineering of sphingomyelin synthases.Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.Sphingomyelin synthase 2 promotes H2O2-induced endothelial dysfunction by activating the Wnt/β-catenin signaling pathwayRole of sphingolipids in senescence: implication in aging and age-related diseasesInhibitory Effect of Methotrexate on Rheumatoid Arthritis Inflammation and Comprehensive Metabolomics Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry (UPLC-Q/TOF-MS)
P2860
Q28078167-6B0592EF-742D-4E0B-AB3C-AC781662670EQ36362001-85388AFA-8B2A-4A38-8E97-B677DDD81A63Q37493129-B8095551-B29E-4334-906E-9BDDCCFFBE36Q38809404-BF10AB47-9CF2-4B93-809F-71229D87D506Q41039824-DFACC126-44F2-45B5-B104-CB508660D9F8Q41863719-39C6EA3C-B164-4DE7-80BC-48D20F0FD501Q48275464-EFB58BCE-B7B8-4438-9208-13A8C633AA57Q48579084-3278B1B0-E754-4CF8-98A0-9E5A17BE6D31Q50130508-276DDA0B-44D7-49A4-B5F8-F7C34A017F94Q50948168-1754C8E5-589E-45CF-8D0C-B7C517E1F608Q54979802-F38718A3-3F2C-4041-864D-72BB256C791FQ57073296-044E08C3-930B-4E02-8A70-6CF3338A683BQ57177438-116D7679-B82A-4F7E-A1E4-92E05B197A3DQ59138385-53A1652F-8D85-439D-B54D-772BB85C5512
P2860
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
@ast
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
@en
type
label
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
@ast
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
@en
prefLabel
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
@ast
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
@en
P1476
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases
@en
P2093
Chiara Luberto
Mohamad Adada
P356
10.1016/J.CHEMPHYSLIP.2015.07.008
P577
2015-07-19T00:00:00Z